type 2 diabetes mellitus (t2dm)

Showing 1 - 25 of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes (T2DM) Trial in Montréal (ALN-KHK, Placebo)

Recruiting
  • Type 2 Diabetes Mellitus (T2DM)
  • Montréal, Quebec, Canada
    Clinical Trial Site
Mar 7, 2023

Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))

Active, not recruiting
  • Diabetes Mellitus
  • +6 more
  • Nagoya-shi, Aichi, Japan
  • +43 more
Jan 16, 2023

Type 2 Diabetes (T2DM) Trial (Endovascular Denervation System (Netrod))

Not yet recruiting
  • Type 2 Diabetes Mellitus (T2DM)
  • Endovascular Denervation System (Netrod)
  • (no location specified)
Jan 5, 2023

Type 2 Diabetes (T2DM) Trial in Nanjing (Endovascular denervation System (Generator and Catheter ))

Recruiting
  • Type 2 Diabetes Mellitus (T2DM)
  • Endovascular denervation System (Generator and Catheter )
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Southeast University
Jan 2, 2023

Persistence to Basal Insulin in Type 2 Diabetes

Not yet recruiting
  • Type 2 Diabetes Mellitus (T2DM)
    • Chilly-Mazarin, France
      Investigational Site Number :
    Nov 16, 2022

    Type 2 Diabetes (T2DM) Trial in Germany

    Recruiting
    • Type 2 Diabetes Mellitus (T2DM)
      • Germany, Germany
        Investigational site
      Nov 21, 2022

      Food Insecurities, Cardiometabolic Comorbidities, HIV Trial in Winston-Salem (weCare/Secure, Usual Care)

      Recruiting
      • Food Insecurities
      • +4 more
      • weCare/Secure
      • Usual Care
      • Winston-Salem, North Carolina
        Wake Forest Health Sciences
      Nov 15, 2022

      Non-alcoholic Steatohepatitis, Type 2 Diabetes (T2DM), Chronic Kidney Disease Trial in Ruddington (cotadutide solution for

      Completed
      • Non-alcoholic Steatohepatitis
      • +2 more
      • cotadutide solution for injection
      • Ruddington, United Kingdom
        Research Site
      Sep 30, 2022

      Chronic Kidney Disease (CKD), Type 2 Diabetes (T2DM), Coronary Artery Disease (CAD) Trial in Jacksonville (Clopidogrel,

      Active, not recruiting
      • Chronic Kidney Disease (CKD)
      • +2 more
      • Jacksonville, Florida
        University of Florida Jacksonville
      Aug 5, 2022

      Type 2 Diabetes (T2DM) Trial in China, Hong Kong, Taiwan (PB-201, Vildagliptin, PB-201 matched )

      Recruiting
      • Type 2 Diabetes Mellitus (T2DM)
      • Hefei, Anhui, China
      • +41 more
      Feb 7, 2022

      Fatty Liver, Nonalcoholic, NAFLD, Nonalcoholic Fatty Liver Disease Trial in United States (HTD1801, Placebo)

      Completed
      • Fatty Liver, Nonalcoholic
      • +5 more
      • Chandler, Arizona
      • +16 more
      Nov 30, 2021

      Type 2 Diabetes (T2DM) Trial in Tuebingen (Dapagliflozin (Forxiga®), Hydrochlorothiazide 25 mg, Placebo matching Dapagliflozin)

      Withdrawn
      • Type 2 Diabetes Mellitus (T2DM)
      • Dapagliflozin (Forxiga®)
      • +2 more
      • Tuebingen, Germany
        University Hospital Tuebingen, Otfried-Mueller Str. 10
      Dec 8, 2021

      Type 2 Diabetes (T2DM) Trial in Beijing (GLP-1 receptor agonist, Placebo)

      Recruiting
      • Type 2 Diabetes Mellitus (T2DM)
      • GLP-1 receptor agonist
      • Placebo
      • Beijing, Beijing, China
        Beijing University People's Hospital
      Oct 17, 2021

      Type 2 Diabetes (T2DM) Trial in La Jolla (Medical Assistant Health Coaching)

      Completed
      • Type 2 Diabetes Mellitus (T2DM)
      • Medical Assistant Health Coaching
      • La Jolla, California
        Scripps Whittier Diabetes Institute
      Sep 20, 2021

      Multiple Electrode Aggregometry & Clopidogrel Resistance

      Completed
      • Type 2 Diabetes Mellitus (T2DM)
      • +2 more
        • Athens, Haidari, Athens, Greece
        • +2 more
        Apr 8, 2021

        Type 2 Diabetes (T2DM), Nonalcoholic Steatohepatitis Trial in Gainesville (Pioglitazone, Placebo)

        Recruiting
        • Type 2 Diabetes Mellitus (T2DM)
        • Nonalcoholic Steatohepatitis
        • Gainesville, Florida
          University of Florida
        Jan 11, 2021

        Type 2 Diabetes (T2DM) Trial in Miami (LIK066, Placebo)

        Completed
        • Type 2 Diabetes Mellitus (T2DM)
        • Miami, Florida
          Novartis Investigative Site
        Dec 11, 2020

        Type 2 Diabetes (T2DM) Trial in Phoenix (Saxagliptin, Placebo)

        Completed
        • Type 2 Diabetes Mellitus (T2DM)
        • Phoenix, Arizona
          Carl T. Hayden VA Medical Hospital
        Mar 11, 2020

        Type 2 Diabetes (T2DM) Trial in Miami (PB-119 100 µg+ Glucophage®, PB-119 150 µg+ Glucophage®, PB-119 200 µg+ Glucophage®)

        Completed
        • Type 2 Diabetes Mellitus (T2DM)
        • PB-119 100 μg+ Glucophage®
        • +3 more
        • Miami, Florida
          Clinical Pharmacology of Miami
        Jan 21, 2020

        Type 2 Diabetes (T2DM) Trial in Kazan, Moscow (Lifestyle intervention)

        Completed
        • Type 2 Diabetes Mellitus (T2DM)
        • Lifestyle intervention
        • Kazan, Russian Federation
        • +1 more
        Apr 11, 2019

        Type 2 Diabetes (T2DM) Trial in Abbotsford, Vancouver (Group Appointments, Individual Appointments (IAs))

        Unknown status
        • Type 2 Diabetes Mellitus (T2DM)
        • Group Appointments
        • Individual Appointments (IAs)
        • Abbotsford, British Columbia, Canada
        • +1 more
        Nov 20, 2017

        Coronary Heart Disease, Acute Coronary Syndrome, Impaired Glucose Tolerance Trial in China, Hong Kong (Acarbose, Matching

        Completed
        • Coronary Heart Disease
        • +3 more
        • Hefei, Anhui, China
        • +176 more
        Jul 21, 2017

        Type 2 Diabetes (T2DM) Trial in Canada, United States (CJC-1134-PC Injection, Weekly for CJC-1134-PC Injection)

        Terminated
        • Type 2 Diabetes Mellitus (T2DM)
        • CJC-1134-PC Injection
        • Weekly placebo for CJC-1134-PC Injection
        • Phoenix, Arizona
        • +21 more
        Jun 21, 2017

        Healthy, Type 2 Diabetes (T2DM) Trial in South Miami, Singapore (LY3298176, Placebo, Dulaglutide)

        Completed
        • Healthy
        • Type 2 Diabetes Mellitus (T2DM)
        • South Miami, Florida
        • +1 more
        Jun 28, 2017